SCHEMBL3708294

SCHEMBL3708294

CC[C@@H](C)[CH]C(=O)NCc1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
LMNA P02545 2/20 0.43
TGM2 P21980 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TRPV1 Q8NER1 1/20 0.40
KDM4E B2RXH2 1/20 0.40
F13A1 P00488 1/20 0.40
APAF1 O14727 1/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232953 0.86 HPGD (0.56) LMNAALDH1A1HPGDMEN1KMT2A
SCHEMBL3668457 0.83 MMP1 (0.43) MMP1MMP2MMP9CNR1CNR2
SCHEMBL3713897 0.79 MAPT (0.49) MMP1MMP2MMP9TGM2ALDH1A1
SCHEMBL26129940 0.77 KMT2A (0.63) LMNAALDH1A1HPGDKMT2AUSP2
SCHEMBL13212291 0.77 LMNA (0.53) CNR1CNR2LMNAALDH1A1HPGD
SCHEMBL18887748 0.74 ERCC1 (0.67) LMNAHPGDMEN1KMT2ATRPV1
SCHEMBL124217 0.74 TGM2 (0.71) MMP1MMP2MMP9CNR1CNR2
SCHEMBL21301524 0.74 MMP1 (0.53) MMP1MMP2MMP9CNR1CNR2
SCHEMBL4948472 0.73 ERCC1 (0.51) LMNAHPGDMEN1KMT2ATRPV1
SCHEMBL17667847 0.73 ERCC1 (0.51) LMNAHPGDMEN1KMT2ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541462-B2 Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors AETERNA ZENTARIS GMBH (DE) 2013-09-24 US disclosed
US-20120122763-A1 NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS AETERNA ZENTARIS GMBH (DE) 2012-05-17 US disclosed
US-20090170783-A1 NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS AETERNA ZENTARIS GMBH (DE) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170783-A1 NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS GPR88, GPR34, GPR27 MMP1 4740/4885MMP2 4525/4885MMP9 4545/4885
US-20120122763-A1 NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS GPR88, GPR34, GPR27 MMP1 4740/4885MMP2 4525/4885MMP9 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.